A
Power Law company profile
Aliada Therapeutics
Biotech & Life Sciences · Boston, United States · Founded 2021 Unicorn
Global footprint
Where Aliada Therapeutics has talent and traffic
Web traffic by country
110
monthly visits
across markets
across markets
🇺🇸 United States90.9%
Patent intelligence
$213k patent portfolio · 3 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$213k
0.02% of valuation · 1154.9× smaller than top peer Arrowhead Pharmaceuticals ($246M)
3 active patent families
Where Aliada Therapeutics innovates
Nucleic acidMonoclonalAnti antibodyAntigen Binding FragmentAntiendomysial antibodies
Above peer median on Strategic, Technology · Below peer median on Market
Quality vs same-sector peers
Aliada Therapeutics on the five Patsnap quality dimensions
Aliada Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Aliada Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Aliada Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Aliada Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.